Simon Stamm
13Patents
4h-index
11Co-inventors
49Inventor score
Filing activity: Jul 20, 2012 → Mar 13, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| USD949797S1 | Connector for electric vehicle | General | 13 | Active |
| US10065929B2 | Pyrazole compounds and their use as T-type calcium channel blockers | Chemistry; Metallurgy | 4 | Active |
| US9932314B2 | Pyrazole compounds and their use as T-type calcium channel blockers | Chemistry; Metallurgy | 4 | Active |
| US9221832B2 | Heterocyclic amide derivatives as P2X7 receptor antagonists | Chemistry; Metallurgy | 4 | Active |
| US10246426B2 | Triazole compounds as T-type calcium channel blockers | Chemistry; Metallurgy | 4 | Active |
| US11685729B2 | C5a receptor modulators | Chemistry; Metallurgy | 0 | Active |
| US11739070B2 | C5A receptor modulators | Chemistry; Metallurgy | 0 | Active |
| US9718774B2 | Indole carboxamide derivatives as P2X7 receptor antagonist | Chemistry; Metallurgy | 0 | Active |
| US9409917B2 | Heterocyclic amide derivatives as P2X7 receptor antagonists | Human Necessities | 0 | Active |
| US9556117B2 | Indole carboxamide derivatives as P2X7 receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US9388197B2 | Heterocyclic amide derivatives as P2X7 receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US9388198B2 | Heterocyclic amide derivatives as P2X7 receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US11608341B2 | Substituted tetrahydropyrazolo[3,4-d]pyrimidines and tetrahydropyrazolo[4,3-d]pyrimidines as C5A receptor modulators | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.